| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.08 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.074 | 0.09 |